159 related articles for article (PubMed ID: 17059412)
21. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
22. Shear stress-induced myosin association with cytoskeleton and phosphorylation in human platelets.
Nakai K; Hayashi T; Nagaya S; Toyoda H; Yamamoto M; Shiku H; Ikeda Y; Nishikawa M
Life Sci; 1997; 60(11):PL181-91. PubMed ID: 9076328
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain.
Roberts W; Michno A; Aburima A; Naseem KM
J Thromb Haemost; 2009 Dec; 7(12):2106-15. PubMed ID: 19765213
[TBL] [Abstract][Full Text] [Related]
24. The Pro33 isoform of integrin beta3 enhances outside-in signaling in human platelets by regulating the activation of serine/threonine phosphatases.
Vijayan KV; Liu Y; Sun W; Ito M; Bray PF
J Biol Chem; 2005 Jun; 280(23):21756-62. PubMed ID: 15826939
[TBL] [Abstract][Full Text] [Related]
25. A novel heterozygous ITGB3 p.T720del inducing spontaneous activation of integrin αIIbβ3 in autosomal dominant macrothrombocytopenia with aggregation dysfunction.
Miyashita N; Onozawa M; Hayasaka K; Yamada T; Migita O; Hata K; Okada K; Goto H; Nakagawa M; Hashimoto D; Kahata K; Kondo T; Kunishima S; Teshima T
Ann Hematol; 2018 Apr; 97(4):629-640. PubMed ID: 29380037
[TBL] [Abstract][Full Text] [Related]
26. Molecular phenotype and bleeding risks of an inherited platelet disorder in a family with a RUNX1 frameshift mutation.
Badin MS; Iyer JK; Chong M; Graf L; Rivard GE; Waye JS; Paterson AD; Pare G; Hayward CPM
Haemophilia; 2017 May; 23(3):e204-e213. PubMed ID: 28181366
[TBL] [Abstract][Full Text] [Related]
27. Altered myosin light-chain phosphorylation in resting platelets from premenopausal women with diabetes.
Guzmán CB; Walsh M; Reddy V; Donthireddy V; Mahmood F; Bode A; Turner JR; Jacober SJ; Sowers JR
Metabolism; 2001 Feb; 50(2):151-6. PubMed ID: 11229421
[TBL] [Abstract][Full Text] [Related]
28. Amyloid β peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization.
Sonkar VK; Kulkarni PP; Dash D
FASEB J; 2014 Apr; 28(4):1819-29. PubMed ID: 24421399
[TBL] [Abstract][Full Text] [Related]
29. Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor.
Jalagadugula G; Goldfinger LE; Mao G; Lambert MP; Rao AK
Blood Adv; 2018 Apr; 2(7):797-806. PubMed ID: 29632235
[TBL] [Abstract][Full Text] [Related]
30. Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets.
Getz TM; Dangelmaier CA; Jin J; Daniel JL; Kunapuli SP
J Thromb Haemost; 2010 Oct; 8(10):2283-93. PubMed ID: 20670370
[TBL] [Abstract][Full Text] [Related]
31. Spotlight on FLI1, RUNX1, and platelet dysfunction.
Rao AK
Blood; 2013 Dec; 122(25):4004-6. PubMed ID: 24335028
[TBL] [Abstract][Full Text] [Related]
32. Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation.
Nanda N; Bao M; Lin H; Clauser K; Komuves L; Quertermous T; Conley PB; Phillips DR; Hart MJ
J Biol Chem; 2005 Jul; 280(26):24680-9. PubMed ID: 15851471
[TBL] [Abstract][Full Text] [Related]
33. Platelet dysfunction caused by a novel thromboxane A
Bugert P; Fischer L; Althaus K; Knöfler R; Bakchoul T
Platelets; 2020; 31(2):276-279. PubMed ID: 31389738
[TBL] [Abstract][Full Text] [Related]
34. Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain.
Kojok K; Mohsen M; El Kadiry AEH; Mourad W; Merhi Y
J Am Heart Assoc; 2020 Feb; 9(3):e013396. PubMed ID: 32009527
[TBL] [Abstract][Full Text] [Related]
35. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
[TBL] [Abstract][Full Text] [Related]
36. Altered cytoskeleton organization in platelets from patients with MYH9-related disease.
Canobbio I; Noris P; Pecci A; Balduini A; Balduini CL; Torti M
J Thromb Haemost; 2005 May; 3(5):1026-35. PubMed ID: 15869600
[TBL] [Abstract][Full Text] [Related]
37. MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9.
Gilles L; Bluteau D; Boukour S; Chang Y; Zhang Y; Robert T; Dessen P; Debili N; Bernard OA; Vainchenker W; Raslova H
Blood; 2009 Nov; 114(19):4221-32. PubMed ID: 19724058
[TBL] [Abstract][Full Text] [Related]
38. Linezolid-Induced Thrombocytopenia Is Caused by Suppression of Platelet Production via Phosphorylation of Myosin Light Chain 2.
Tajima M; Kato Y; Matsumoto J; Hirosawa I; Suzuki M; Takashio Y; Yamamoto M; Nishi Y; Yamada H
Biol Pharm Bull; 2016; 39(11):1846-1851. PubMed ID: 27803456
[TBL] [Abstract][Full Text] [Related]
39. Effect of 2-arachidonoylglycerol on myosin light chain phosphorylation and platelet activation: The role of phosphatidylinositol 3 kinase/AKT pathway.
Signorello MG; Leoncini G
Biochimie; 2014 Oct; 105():182-91. PubMed ID: 25068972
[TBL] [Abstract][Full Text] [Related]
40. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
Egot M; Lasne D; Poirault-Chassac S; Mirault T; Pidard D; Dreano E; Elie C; Gandrille S; Marchelli A; Baruch D; Rendu J; Fauré J; Flaujac C; Gratacap MP; Sié P; Gaussem P; Salomon R; Baujat G; Bachelot-Loza C
Br J Haematol; 2021 Mar; 192(5):909-921. PubMed ID: 33528045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
